|
|
|
|
Selecting a fill-finish line before making packaging decisions creates compounding risks. Learn how early collaboration among container suppliers, OEM partners, and drug developers shapes equipment capability, regulatory readiness, and manufacturing flexibility.
|
|
|
|
|
Reliable container closure system design means coordinating materials science, equipment compatibility, and contamination control across every stage of fill-finish. Review the technical variables that determine whether a CCS performs reliably at scale.
|
|
|
|
|
Protecting drug product in fill-finish depends on designing filling, environmental control, and verification strategies to work together. Understand the engineering considerations and tradeoffs that influence sterility assurance and regulatory confidence.
|
|
|
|
|
No single intervention can address particulate risk in aseptic manufacturing. Environmental conditions and mechanical interactions each contribute to contamination risk. See how design decisions across both combine to support a credible control strategy.
|
|
|
|
|
Fill-finish equipment decisions made during clinical development carry significant implications at commercial scale. Find out how transport mechanisms, pump selection, and format flexibility factor into a long-term aseptic manufacturing strategy.
|
|
|
|
|
|
|
|
|
Meet West at Pharmapack in Paris, France from January 27-28, 2027. Team Members will be at Stand 4G66 to answer questions about our latest offerings. To schedule a meeting, please email meetwest@westpharma.com.
|
|
|
